[APLS] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
26-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -1.35%
YoY- -99.71%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 60,290 250,000 -142 12 12 0 0 -
PBT -147,581 80,110 -113,217 -36,459 -18,256 -6,620 -6,947 66.34%
Tax 352 2 3,981 2,383 -17,896 -6,679 1,269 -19.22%
NP -147,933 78,265 -113,217 -36,459 -18,256 -6,620 -8,216 61.82%
Tax Rate - -0.00% - - - - - -
Total Cost 208,223 171,735 113,075 36,471 18,267 6,620 8,216 71.30%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -245.37 31.31 79,646.45 -315,885.24 -158,169.26 0.00 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -1.73 0.99 -1.54 -0.65 -0.36 -0.37 -0.45 25.13%
EPS Diluted -1.73 0.99 -1.54 -0.63 -0.36 -0.37 -0.45 25.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.